Xenothera is a xenotherapy platform with embedded technology that renovates immunological treatments. Founded by Jean-Paul Soulillou in 2014, Xenothera is backed by investors that include Bpifrance, European Innovation Council, Anaxago, EASME – EU Executive Agency for SMEs, and Starquest Capital and is headquartered in Nantes.